Intrathoracic Accessory Lobe of the Liver
A 20-year-old woman presented with a rectal mass that was malignant on biopsy. Chest radiograph and abdominal CT were ordered to look for metastases.
Clinical History: A 20-year-old woman presented to the physician with a rectal mass that was malignant on biopsy. Chest radiograph and abdominal CT were ordered to look for metastases.
Figure 1: Chest radiograph (PA view) showing a lobulated mass obliterating the right costophrenic angle and the diaphragm.
Figure 2:
Coronal maximum intensity projection computed tomography image shows the lesion to be lobulated, isodense to liver and getting supply from right posterior branch of the portal vein (arrow).
Findings:
Her chest radiograph (postero-anterior view) shows a lobulated mass obliterating the right costophrenic angle and the diaphragm (Figure 1). Coronal maximum intensity reformatted CT image (Figure 2) shows the lesion to be lobulated, isodense to liver and getting supply from right posterior branch of the portal vein. The orthotopic liver was normal in configuration. Biopsy from the mass was done which showed normal liver tissue.
Diagnosis: Intrathoracic accessory lobe of the liver
Discussion: If the tissue is in communication with the main liver, it is termed as an accessory lobe, and it is termed ectopic if there is no communication [1]. Intrathoracic accessory lobe of the liver shows attenuation and morphology similar to that of normal orthotopic liver. As the development of both liver and diaphragm are closely related, this anomaly could be due to persistence of the pleuro-peritoneal canal [2].
References:
1. Collan Y, Hakkiluoto A, Hastbacka J: Ectopic Liver. Ann Chir Gynaecol 1978; 67: 27-29.
2. Roux BT. Heterotopic intrathoracic liver. Thorax 1961; 16: 68.
Shivali V Kashikar, MD, associate professor, Department of Radiodiagnosis, Jawaharlal Nehru Medical College, India; and Amol Gulkari, MD, consultant radiologist
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
